A Retrospective Multicenter Italian Analysis of Epidemiological, Clinical and Histopathological Features in a Sample of Patients with Acinic Cell Carcinoma of the Parotid Gland

Author:

De Luca Pietro1ORCID,Di Stadio Arianna2ORCID,de Campora Luca3,De Bonis Egidio4,Fermi Matteo5ORCID,Petruzzi Gerardo6ORCID,Atturo Francesca3,Colangeli Roberta7,Scarpa Alfonso8,Lo Manto Alfredo9,Colizza Andrea10ORCID,Cintoli Giulia11,Togo Giulia12,Salzano Giovanni12,Crescenzi Domenico1,Ralli Massimo10ORCID,Abbate Vincenzo12ORCID,Ricciardiello Filippo13,Magaldi Luciano11,D’Ecclesia Aurelio14,di Massa Gianluca15,Costarelli Leopoldo16ORCID,Merenda Elisabetta17ORCID,Corsi Alessandro17ORCID,Covello Renato18,Di Crescenzo Rosa Maria19,Duda Loren20,Dimitri Lucia Maria21,Caputo Alessandro22,Ferrara Gerardo23,Lucante Teresina24,Longo Francesco14ORCID,Tassone Domenico3,Iemma Maurizio4,Cassano Michele11,Salzano Francesco Antonio8,Califano Luigi12,Marchioni Daniele9,Pellini Raul6ORCID,de Vincentiis Marco10,Presutti Livio5,Ionna Franco25,de Campora Enrico26,Radici Marco1,Camaioni Angelo3

Affiliation:

1. Otolaryngology Department, Fatebenefratelli Isola Tiberina-Gemelli Isola, 00186 Rome, Italy

2. Otolaryngology Unit, University of Catania, 95131 Catania, Italy

3. Otolaryngology Department, San Giovanni-Addolorata Hospital, 00100 Rome, Italy

4. Otolaryngology Unit, San Giovanni di Dio e Ruggi D’Aragona Hospital, 84131 Salerno, Italy

5. Department of Otorhinolaryngology—Head and Neck Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy

6. Department Otolaryngology Head and Neck Surgery, IRCCS Regina Elena National Cancer Institute, Istituti Fisioterapici Ospitalieri (IFO), 00144 Rome, Italy

7. Otolaryngology Department, Sant’Eugenio Hospital, 00144 Rome, Italy

8. Department of Medicine, Surgery and Dentistry, University of Salerno, 84081 Salerno, Italy

9. Otolaryngology Department, University of Modena and Reggio Emilia, 41121 Modena, Italy

10. Department of Sense Organs, University Sapienza, 00161 Rome, Italy

11. Otolaryngology Unit, University of Foggia, 71122 Foggia, Italy

12. Maxillofacial Surgery Unit, Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples “Federico II”, 80100 Naples, Italy

13. Otolaryngology Unit, AORN Cardarelli, 80131 Naples, Italy

14. Maxillofacial and Otolaryngology Unit, IRCCS “Casa Sollievo della Sofferenza” San Giovanni Rotondo, 71013 Foggia, Italy

15. Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, 41124 Modena, Italy

16. Department of Pathology, San Giovanni Addolorata-Hospital, 00184 Rome, Italy

17. Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy

18. Department of Pathology, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy

19. Institute of Experimental Endocrinology and Oncology (IEOS), National Research Council, 80131 Naples, Italy

20. Pathology Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy

21. Department of Pathology, IRCCS “Casa Sollievo della Sofferenza” San Giovanni Rotondo, 71013 Foggia, Italy

22. Pathology Unit, San Giovanni di Dio e Ruggi D’Aragona University Hospital, 84131 Salerno, Italy

23. Department of Pathology, INT-IRCCS “Fondazione G. Pascale”, 80131 Naples, Italy

24. Department of Pathology, Fatebenefratelli Isola Tiberina-Gemelli Isola, 00186 Rome, Italy

25. Maxillofacial Unit, INT-IRCCS “Fondazione G. Pascale”, 80131 Naples, Italy

26. Associazione Ospedaliera Italia Centro-Meridionale Otorinolaringoiatrica (AOICO), 00100 Rome, Italy

Abstract

Background. The acinic cell carcinoma (AciCC) of the parotid gland is a rare tumor with an indolent behavior; however, a subgroup of this tumor presents an aggressive behavior with a tendency to recur. The aim of this multicenter study was to identify and stratify those patients with AciCC at high risk of tumor recurrence. Methods. A retrospective study was carried out involving 77 patients treated with surgery between January 2000 and September 2022, in different Italian referral centers. Data about tumor characteristics and its recurrence were collected. The histological specimens and slides were independently reviewed by a senior pathologist coordinator (L.C.) and the institution’s local head and neck pathologist. Results. The patients’ age average was 53.6 years, with a female prevalence in the group. The mean follow-up was 67.4 months (1-258, SD 59.39). The five-year overall survival (OS) was 83.2%. The 5-year disease-free survival (DFS) was 60% (95% CI 58.2–61.7). A high incidence of necrosis, extraglandular spread, lymphovascular invasion (LVI), atypical mitosis, and cellular pleomorphism was observed in the high-risk tumors compared to the low-risk ones. Conclusion. AciCC generally had an indolent behavior, optimal OS, DFS with few cervical node metastases, and rare distant relapses. This multicenter retrospective case series provides evidence of the need for clinical–epidemiological–histological stratification for patients at risk of poor outcomes. Our results suggest that the correct definition of high-risk AciCC should include tumor size, the presence of necrosis, extraglandular spread, LVI, atypical mitosis, and cellular pleomorphism.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference33 articles.

1. Acinic cell carcinoma of the parotid gland: From pathogenesis to management: A literature review;Cavaliere;Eur. Arch. Oto-Rhino-Laryngol.,2020

2. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands;Hyrcza;Head Neck Pathol.,2022

3. Acinic cell adenocarcinoma of the parotid gland; report of twenty-seven cases;Godwin;Am. J. Pathol.,1954

4. Surgical treatment of epithelial tumors of the parotid gland;Buxton;Surg. Gynecol. Obstet.,1954

5. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland;Stanley;Otolaryngol. Head Neck Surg.,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3